Daily acyclovir may stop herpes Flare-Ups in rheumatic patients
NCT ID NCT07341386
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study tests whether taking acyclovir daily can prevent herpes simplex outbreaks in people with autoimmune rheumatic diseases like lupus or rheumatoid arthritis. 62 participants will receive either acyclovir or a placebo for 12 months and be monitored for 24 months total. The goal is to see if this approach reduces the number of herpes episodes and is safe for long-term use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE RHEUMATIC DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Reumatology division of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Sao Paulo 05403-000
RECRUITINGSão Paulo, São Paulo, 05403-000, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A family therapy could curb early psychosis risk in youth
- Yearly TB check may shield vulnerable patients from a hidden threat
- Emergency rooms as prevention hubs: personalized advice may improve health behaviors
- Could a single pill after sex stop STIs in women?
- Can free meal kits from a food pantry boost healthy eating?
- Can a One-Session therapy help displaced people avoid substance abuse?